{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:14:43Z","timestamp":1740147283494,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cancer antigen 15-3 is a protein that clinicians commonly measure to monitor outcomes and response to treatment in patients with breast cancer. However, cancer antigen 15-3 can also be elevated in other, benign and malignant conditions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 73-year-old White woman with history of breast cancer presented to her primary care physician with right hip pain, and laboratory testing revealed elevated cancer antigen 15-3. Further workup with radiographic imaging revealed a large mass in her right kidney. The renal mass was subsequently removed, and the cancer antigen 15-3 level returned to normal.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Elevation of cancer antigen 15-3 owing to causes other than breast cancer recurrence can be a potential diagnostic pitfall during a patient\u2019s follow-up. It is important for clinicians to be aware of the limitations of cancer markers and to utilize a combination of diagnostic tests for patient evaluation.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13256-023-04088-5","type":"journal-article","created":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T11:02:49Z","timestamp":1701946969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elevation of cancer antigen 15-3 owing to oncocytic renal neoplasm in a patient without evidence of breast cancer recurrence on follow-up: a case report"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9034-0273","authenticated-orcid":false,"given":"Samuel G.","family":"Cockey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzhi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5164-9163","authenticated-orcid":false,"given":"Mohammed","family":"Al-Jumayli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,12,7]]},"reference":[{"issue":"2","key":"4088_CR1","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.bbcan.2014.01.001","volume":"1845","author":"K Mehla","year":"2014","unstructured":"Mehla K, Singh PK. MUC1: a novel metabolic master regulator. Biochim Biophys Acta. 2014;1845(2):126\u201335. https:\/\/doi.org\/10.1016\/j.bbcan.2014.01.001.","journal-title":"Biochim Biophys Acta"},{"key":"4088_CR2","doi-asserted-by":"publisher","first-page":"9863092","DOI":"10.1155\/2018\/9863092","volume":"2018","author":"X Li","year":"2018","unstructured":"Li X, Dai D, Chen B, Tang H, Xie X, Wei W. Clinicopathological and prognostic significance of cancer antigen 15-3 and carcinoembryonic antigen in breast cancer: a meta-analysis including 12,993 patients. Dis Mark. 2018;2018:9863092. https:\/\/doi.org\/10.1155\/2018\/9863092.","journal-title":"Dis Mark"},{"issue":"1","key":"4088_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227356","volume":"15","author":"A Perrier","year":"2020","unstructured":"Perrier A, Boelle PY, Chretien Y, et al. An updated evaluation of serum sHER2, CA15.3, and CEA levels as biomarkers for the response of patients with metastatic breast cancer to trastuzumab-based therapies. PLoS ONE. 2020;15(1): e0227356. https:\/\/doi.org\/10.1371\/journal.pone.0227356.","journal-title":"PLoS ONE"},{"issue":"7","key":"4088_CR4","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1200\/JCO.2012.45.9859","volume":"31","author":"JL Khatcheressian","year":"2013","unstructured":"Khatcheressian JL, Hurley P, Bantug E, et al. Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol. 2013;31(7):961\u20135. https:\/\/doi.org\/10.1200\/JCO.2012.45.9859.","journal-title":"J Clin Oncol"},{"issue":"1","key":"4088_CR5","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s40792-015-0128-z","volume":"1","author":"Y Adachi","year":"2015","unstructured":"Adachi Y, Kikumori T, Miyajima N, et al. Postoperative elevation of CA15-3 due to pernicious anemia in a patient without evidence of breast cancer recurrence. Surg Case Rep. 2015;1(1):126. https:\/\/doi.org\/10.1186\/s40792-015-0128-z.","journal-title":"Surg Case Rep"},{"key":"4088_CR6","doi-asserted-by":"publisher","first-page":"979","DOI":"10.3332\/ecancer.2019.979","volume":"13","author":"B Buonomo","year":"2019","unstructured":"Buonomo B, Noli SA, Santini A, Alviggi C, Peccatori FA. Can we trust tumour markers in pregnancy after breast cancer? A case of elevated CA 15-3 in the third trimester of pregnancy normalising after delivery. Ecancermedicalscience. 2019;13:979. https:\/\/doi.org\/10.3332\/ecancer.2019.979.","journal-title":"Ecancermedicalscience"},{"issue":"4","key":"4088_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1075-122X.2004.21369.x","volume":"10","author":"D Aguiar-Bujanda","year":"2004","unstructured":"Aguiar-Bujanda D, Bohn-Sarmiento U, Aguiar-Morales J. False elevation of serum CA 15-3 levels in patients under follow-up for breast cancer. Breast J. 2004;10(4):375\u20136. https:\/\/doi.org\/10.1111\/j.1075-122X.2004.21369.x.","journal-title":"Breast J"},{"issue":"2","key":"4088_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/S1470-2045(00)00227-8","volume":"2","author":"JP Ghnassia","year":"2001","unstructured":"Ghnassia JP, Rodier JF, Eber M. Elevation of CA15-3 caused by a benign tumour. Lancet Oncol. 2001;2(2):102. https:\/\/doi.org\/10.1016\/S1470-2045(00)00227-8.","journal-title":"Lancet Oncol"},{"key":"4088_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-214549","author":"J Bevan","year":"2016","unstructured":"Bevan J, Richardson M. Diminution of falsely elevated tumour markers following immunosuppression for systemic lupus erythematosus with neurological involvement. BMJ Case Rep. 2016. https:\/\/doi.org\/10.1136\/bcr-2016-214549.","journal-title":"BMJ Case Rep"},{"key":"4088_CR10","doi-asserted-by":"publisher","first-page":"2039730","DOI":"10.1155\/2018\/2039730","volume":"2018","author":"S Tsiodras","year":"2018","unstructured":"Tsiodras S, Gouloumi AR, Tsakiraki Z, et al. Falsely elevated CA 15-3 levels in ovarian sarcoidosis with peritoneal involvement and ascites. Case Rep Obstet Gynecol. 2018;2018:2039730. https:\/\/doi.org\/10.1155\/2018\/2039730.","journal-title":"Case Rep Obstet Gynecol"},{"issue":"9","key":"4088_CR11","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/s1579-2129(07)60117-7","volume":"43","author":"L AltubeUrrengoetxea","year":"2007","unstructured":"AltubeUrrengoetxea L, Salinas Solano C, AburtoBarrenetxea M, Moraza Cortes FJ, Ballaz Quincoces A, Capelastegui SA. Accelerated phase of idiopathic pulmonary fibrosis [Fase acelerada de la fibrosis pulmonar idiopatica]. Arch Bronconeumol. 2007;43(9):516\u20138. https:\/\/doi.org\/10.1016\/s1579-2129(07)60117-7.","journal-title":"Arch Bronconeumol"},{"issue":"2","key":"4088_CR12","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/pl00008210","volume":"436","author":"Y Cao","year":"2000","unstructured":"Cao Y, Karsten U, Zerban H, Bannasch P. Expression of MUC1, Thomsen-Friedenreich-related antigens, and cytokeratin 19 in human renal cell carcinomas and tubular clear cell lesions. Virchows Arch. 2000;436(2):119\u201326. https:\/\/doi.org\/10.1007\/pl00008210.","journal-title":"Virchows Arch"},{"issue":"24","key":"4088_CR13","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1200\/JCO.2015.61.1459","volume":"33","author":"C Van Poznak","year":"2015","unstructured":"Van Poznak C, Somerfield MR, Bast RC, et al. Use of biomarkers to guide decisions on systemic therapy for women with metastatic breast cancer: American society of clinical oncology clinical practice guideline. J Clin Oncol. 2015;33(24):2695\u2013704. https:\/\/doi.org\/10.1200\/JCO.2015.61.1459.","journal-title":"J Clin Oncol"},{"issue":"15_suppl","key":"4088_CR14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.15_suppl.e23051","volume":"35","author":"ME Shaikh","year":"2017","unstructured":"Shaikh ME, Hall S, Wen S, Liu H, Miah A, Salkeni MA. Retrospective analysis of the role of CA 15-3 as a biomarker for breast cancer relapse. J Clin Oncol. 2017;35(15_suppl): e23051. https:\/\/doi.org\/10.1200\/JCO.2017.35.15_suppl.e23051.","journal-title":"J Clin Oncol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-04088-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-023-04088-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-023-04088-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T11:05:30Z","timestamp":1701947130000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-023-04088-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,7]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4088"],"URL":"https:\/\/doi.org\/10.1186\/s13256-023-04088-5","relation":{},"ISSN":["1752-1947"],"issn-type":[{"type":"electronic","value":"1752-1947"}],"subject":[],"published":{"date-parts":[[2023,12,7]]},"assertion":[{"value":"23 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study did not require Institutional Review Board approval because it does not meet the United States Department of Health and Human Services\u2019 definition of research. This work follows the principles of the Declaration of Helsinki. The patient provided consent to participate in this case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"We have no conflicts of interest with respect to this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"526"}}